Eye Drops and Lubricants Drugs Market Growth, Size, Trends, Revenue, Share and Future Outlook: SPER Market Research

Q: How can I get a sample report on Eye Drops and Lubricants Drugs Market?

"You can get the sample pages by clicking the link - Click Here "

Published: Dec 2023	Report ID: HLCA2379	Pages: 1 - 224	Formats^*:
Category : Healthcare

Eye Drops and Lubricants Drugs Market Introduction and Overview

According to SPER Market Research, the Global Eye Drops and Lubricants Drugs Market is estimated to reach USD 33.47 million by 2033 with CAGR of 5.2%.

The report includes an in-depth analysis of the Global Eye Drops and Lubricants Drugs Market, including market size and trends, product mix, applications, and supplier analysis. Eye drops are used to treat a variety of eye conditions, including allergies, inflammation, irritation, pain, swelling, and redness, dryness, and infection (pink eye). Hormonal imbalances are among the many illnesses that are being caused by an increase in the working population. Problems with the eyes and vision are also caused by hormone imbalance. Because they are more convenient, less uncomfortable, and effective for a range of eye conditions, eye drops and lubricants come to the rescue.

July 2021: Bausch + Lomb announced that BiotrueÂ® Micellar Eyelid Cleansing Wipes and BiotrueÂ® Hydration Boost Lubricant Eye Drops was launched in the United States. The two solutions are designed to reduce symptoms of disease associated with dry, inflamed eyes. They are free of preservatives and infrequently contain organically recommended ingredients.

October 2021: Additionally, Allergan, an AbbVie subsidiary, revealed that the FDA had approved Vuity, an eye drop, for the treatment of presbyopia. This might allow millions of people to forgo reading glasses.

Market Opportunities and Challenges

The market is expanding as a result of the growing use of hormone therapy, which includes hormone eye drops and lubricants. Global postmenopausal women and SjÃ¶gren's patients are seeing an increasing incidence of dry eye, which is driving market expansion. Opportunities for the market's expansion are created by the rise in open angle glaucoma therapies supplied through retail pharmacies and the boom in the number of retail pharmacies in developed nations. Furthermore, because retail pharmacies are more conveniently accessible, patients prefer to buy their medications from them.

The expiration of patent protection for well-known drugs used to treat eye conditions and the lack of health insurance in developing nations are expected to limit market expansion. Pricing patterns indicate that during the next few years, market expansion may be constrained by the high cost of product development. The lack of qualified workers will be a barrier to the ophthalmic medicine business, and the side effects of ophthalmic pharmaceuticals could reduce sales. The availability of alternative therapies and the high cost of specialty dry eye solutions with intricate reimbursement scenarios, however, are expected to hinder the market's expansion over the projected period.

Get more information on this report: Download Free Sample PDF

Market Competitive Landscape

The market participants of the industry concentrate on taking advantage of the current business prospects in the eye drop industry by growing and broadening their market presence and gaining a new clientele. New items are being introduced to the market by market players. Major key players are Bausch Health Companies Inc., Teva Pharmaceutical Industries Ltd. (Israel), EyePoint Pharmaceuticals,Inc, Bayer AG, Novartis AG, Nidek Co Ltd, Prestige Consumer Healthcare Inc. and others.

Scope of the Report:

Report Metric	Details
Market size available for years	2019-2033
Base year considered	2022
Forecast period	2023-2033
Segments covered	By Indication, By Type, By Distribution Channel, By End-User
Regions covered	North America, Asia-Pacific, Latin America, Middle East & Africa and Europe
Companies Covered	Bausch Health Companies Inc., Teva Pharmaceutical Industries Ltd. (Israel), Eye Point Pharmaceuticals, Inc, Bayer AG, Novartis AG, Nidek Co Ltd, Prestige Consumer Healthcare Inc. and others

COVID-19 Impact on Global Eye Drops and Lubricants Drugs Market

COVID-19 has caused an unparalleled worldwide public health emergency that has affected almost all businesses. Its long-term effects are anticipated to have an impact on industry growth in the predicted period. The shift in the healthcare system to handle COVID-19 has resulted in postponed clinical trial results and cancelled drug launches. The eyes serve as a point of contact for direct aerosol inoculation entrance or escape. Furthermore, as hands can come into contact with secretions from tears and potentially spread the virus, patients' hands can also be a point of infection for other patients. Consequently, this will have a big effect on the market for lubricants and eye drops.

Key Target Audience:

Eye drop manufacturers, suppliers, distributors and other stakeholders
Government bodies such as regulating authorities and policy makers
Organizations, forums and alliances related to eye drops
Market research and consulting firms

Our in-depth analysis of the Eye Drops and Lubricants Drugs Market includes the following segments:

By Indication:	Conjunctivitis Dry Eye Glaucoma Refractive Errors
By Type:	Artificial Tears Antibiotics Hormones
By Distribution Channel:	Hospital Pharmacy Online Pharmacy Retail Pharmacy
By End-User:	Homecare Hospitals Specialty Clinics Others

Key Topics Covered in the Report:

Global Eye Drops and Lubricants Drugs Market Size (FYâ€™2023-FYâ€™2033)
Overview of Global Eye Drops and Lubricants Drugs Market
Segmentation of Global Eye Drops and Lubricants Drugs Market By Indication (Conjunctivitis, Dry Eye, Glaucoma, Refractive Errors)
Segmentation of Global Eye Drops and Lubricants Drugs Market By Type (Antibiotics, Hormones and Artificial Tears)
Segmentation of Global Eye Drops and Lubricants Drugs Market By Distribution Channel (Hospital Pharmacy, Online Pharmacy and Retail Pharmacy)
Segmentation of Global Eye Drops and Lubricants Drugs Market By End-User (Hospitals, Homecare, Specialty Clinics and Others)
Statistical Snap of Global Eye Drops and Lubricants Drugs Market
Expansion Analysis of Global Eye Drops and Lubricants Drugs Market
Problems and Obstacles in Global Eye Drops and Lubricants Drugs Market
Competitive Landscape in the Global Eye Drops and Lubricants Drugs Market
Impact of COVID-19 and Demonetization on Global Eye Drops and Lubricants Drugs Market
Details on Current Investment in Global Eye Drops and Lubricants Drugs Market
Competitive Analysis of Global Eye Drops and Lubricants Drugs Market
Prominent Players in the Global Eye Drops and Lubricants Drugs Market
SWOT Analysis of Global Eye Drops and Lubricants Drugs Market
Fire Alarm and Detection Market Future Outlook and Projections (FYâ€™2023-FYâ€™2033)
Recommendations from Analyst

1. Introduction

1.1. Scope of the report
1.2. Market segment analysis

2. Research Methodology

2.1. Research data source
2.1.1. Secondary Data
2.1.2. Primary Data
2.1.3. SPERâ€™s internal database
2.1.4. Premium insight from KOLâ€™s
2.2. Market size estimation
2.2.1. Top-down and Bottom-up approach
2.3. Data triangulation

3. Executive Summary

4. Market Dynamics

4.1. Driver, Restraint, Opportunity and Challenges analysis
4.1.1. Drivers
4.1.2. Restraints
4.1.3. Opportunities
4.1.4. Challenges
4.2. COVID-19 Impacts of the Global Eye Drops and Lubricants Drugs Market

5. Market variable and outlook

5.1. SWOT Analysis
5.1.1. Strengths
5.1.2. Weaknesses
5.1.3. Opportunities
5.1.4. Threats
5.2. PESTEL Analysis
5.2.1. Political Landscape
5.2.2. Economic Landscape
5.2.3. Social Landscape
5.2.4. Technological Landscape
5.2.5. Environmental Landscape
5.2.6. Legal Landscape
5.3. PORTERâ€™s Five Forces
5.3.1. Bargaining power of suppliers
5.3.2. Bargaining power of buyers
5.3.3. Threat of Substitute
5.3.4. Threat of new entrant
5.3.5. Competitive rivalry
5.4. Heat Map Analysis

6. Competitive Landscape

6.1. Global Eye Drops and Lubricants Drugs Market Manufacturing Base Distribution, Sales Area, Product Type
6.2. Mergers & Acquisitions, Partnerships, Product Launch, and Collaboration in Global Eye Drops and Lubricants Drugs Market

7. Global Eye Drops and Lubricants Drugs Market, By Indication (USD Million)

7.1. Global Eye Drops and Lubricants Market Value Share and Forecast, By Indication, 2023-2033
7.2. Conjunctivitis
7.3. Dry Eye
7.4. Glaucoma
7.5. Refractive Errors
7.6. Others

8. Global Eye Drops and Lubricants Drugs Market, By Type (USD Million)

8.1. Global Eye Drops and Lubricants Market Value Share and Forecast, By Type, 2023-2033
8.2. Artificial Tears
8.3. Antibiotics
8.4. Hormones
8.5. Others

9. Global Eye Drops and Lubricants Drugs Market, By Distribution Channel (USD Million)

9.1. Global Eye Drops and Lubricants Market Value Share and Forecast, By Distribution Channel, 2023-2033
9.2. Hospital Pharmacy
9.3. Online Pharmacy
9.4. Retail Pharmacy

10. Global Eye Drops and Lubricants Drugs Market, By End-User (USD Million)

10.1. Global Eye Drops and Lubricants Market Value Share and Forecast, By End-User, 2023-2033
10.2. Homecare
10.3. Hospitals
10.4. Specialty Clinics
10.5. Others

11. Global Eye Drops and Lubricants Drugs Market Forecast, 2019-2033 (USD Million)

11.1. Global Eye Drops and Lubricants Drugs Market Size and Market Share

12. Global Eye Drops and Lubricants Drugs Market, By Indication 2019-2033 (USD Million)

12.1. Global Eye Drops and Lubricants Drugs Market Size and Market Share By Indication (2019-2026)
12.2. Global Eye Drops and Lubricants Drugs Market Size and Market Share By Indication (2027-2033)

13. Global Eye Drops and Lubricants Drugs Market, By Type, 2019-2033 (USD Million)

13.1. Global Eye Drops and Lubricants Drugs Market Size and Market Share By Type (2019-2026)
13.2. Global Eye Drops and Lubricants Drugs Market Size and Market Share By Type (2027-2033)

14. Global Eye Drops and Lubricants Drugs Market, By Distribution Channel , 2019-2033 (USD Million)

14.1. Global Eye Drops and Lubricants Drugs Market Size and Market Share By Distribution Channel (2019-2026)
14.2. Global Eye Drops and Lubricants Drugs Market Size and Market Share By Distribution Channel (2027-2033)

15. Global Eye Drops and Lubricants Drugs Market, By End-User, 2019-2033 (USD Million)

15.1. Global Eye Drops and Lubricants Drugs Market Size and Market Share By End-User (2019-2026)
15.2. Global Eye Drops and Lubricants Drugs Market Size and Market Share By End-User (2027-2033)

16. Global Eye Drops and Lubricants Drugs Market, By Region, 2019-2033 (USD Million)

16.1. Global Eye Drops and Lubricants Drugs Market Size and Market Share By Region (2019-2026)
16.2. Global Eye Drops and Lubricants Drugs Market Size and Market Share By Region (2027-2033)
16.3. Asia-Pacific
16.3.1. Australia
16.3.2. China
16.3.3. India
16.3.4. Japan
16.3.5. South Korea
16.3.6. Rest of Asia-Pacific
16.4. Europe
16.4.1. France
16.4.2. Germany
16.4.3. Italy
16.4.4. Spain
16.4.5. United Kingdom
16.4.6. Rest of Europe
16.5. Middle East and Africa
16.5.1. Kingdom of Saudi Arabia
16.5.2. United Arab Emirates
16.5.3. Rest of Middle East & Africa
16.6. North America
16.6.1. Canada
16.6.2. Mexico
16.6.3. United States
16.7. Latin America
16.7.1. Argentina
16.7.2. Brazil
16.7.3. Rest of Latin America

17. Company Profile

17.1. Bausch Health Companies Inc.
17.1.1. Company details
17.1.2. Financial outlook
17.1.3. Product summary
17.1.4. Recent developments
17.2. Bayer AG
17.2.1. Company details
17.2.2. Financial outlook
17.2.3. Product summary
17.2.4. Recent developments
17.3. EyePoint Pharmaceuticals,Inc
17.3.1. Company details
17.3.2. Financial outlook
17.3.3. Product summary
17.3.4. Recent developments
17.4. Fera Pharmaceuticals
17.4.1. Company details
17.4.2. Financial outlook
17.4.3. Product summary
17.4.4. Recent developments
17.5. Kubota Vision Inc
17.5.1. Company details
17.5.2. Financial outlook
17.5.3. Product summary
17.5.4. Recent developments
17.6. Novartis AG
17.6.1. Company details
17.6.2. Financial outlook
17.6.3. Product summary
17.6.4. Recent developments
17.7. Nidek Co Ltd
17.7.1. Company details
17.7.2. Financial outlook
17.7.3. Product summary
17.7.4. Recent developments
17.8. Prestige Consumer Healthcare Inc.
17.8.1. Company details
17.8.2. Financial outlook
17.8.3. Product summary
17.8.4. Recent developments
17.9. Teva Pharmaceutical Industries Ltd.
17.9.1. Company details
17.9.2. Financial outlook
17.9.3. Product summary
17.9.4. Recent developments
17.10. Others

18. List of Abbreviations

19. Reference Links

20. Conclusion

21. Research Scope

SPER Market Research’s methodology uses great emphasis on primary research to ensure that the market intelligence insights are up to date, reliable and accurate. Primary interviews are done with players involved in each phase of a supply chain to analyze the market forecasting. The secondary research method is used to help you fully understand how the future markets and the spending patterns look likes.

The report is based on in-depth qualitative and quantitative analysis of the Product Market. The quantitative analysis involves the application of various projection and sampling techniques. The qualitative analysis involves primary interviews, surveys, and vendor briefings. The data gathered as a result of these processes are validated through experts opinion. Our research methodology entails an ideal mixture of primary and secondary initiatives.

SPER-Methodology-1

SPER-Methodology-2

SPER-Methodology-3

Frequently Asked Questions About This Report

How big is Eye Drops and Lubricants Drugs Market?

Eye Drops and Lubricants Drugs Market is projected to reach USD 33.47 billion by 2033, growing at a CAGR of 5.2% during the forecast period.

What is the growth rate of Eye Drops and Lubricants Drugs Market?

Eye Drops and Lubricants Drugs Market grew in market size from 2023. The Market is expected to reach USD 33.47 billion by 2033, at a CAGR of 5.2% during the forecast period.

What is the anticipated Eye Drops and Lubricants Drugs Market during the forecast period?

Eye Drops and Lubricants Drugs Market CAGR of 5.2% during the forecast period.

How can I get a sample report on Eye Drops and Lubricants Drugs Market?

"You can get the sample pages by clicking the link -Click Here"

What is the market size of Eye Drops and Lubricants Drugs Market?

Eye Drops and Lubricants Drugs Market size is USD 33.47 billion from 2023 to 2033.

Which segment is expected to lead Eye Drops and Lubricants Drugs Market?

Eye Drops and Lubricants Drugs Market Segment is Covered By Indication, By Type, By Distribution Channel, By End-User

Which region is expected to have the highest market share in Eye Drops and Lubricants Drugs Market?

The North America region is anticipated to have the highest market share in Eye Drops and Lubricants Drugs Market.

Who are the key players in Eye Drops and Lubricants Drugs Market?

The key players in the market include Companies Covered Bausch Health Companies Inc., Teva Pharmaceutical Industries Ltd. (Israel), EyePoint Pharmaceuticals,Inc, Bayer AG, Novartis AG, Nidek Co Ltd, Prestige Consumer Healthcare Inc. and others

What is the conclusion of Eye Drops and Lubricants Drugs Market?

Eye drops are used to treat a variety of eye conditions, including allergies, inflammation, irritation, pain, swelling, and redness, dryness, and infection (pink eye).